Biotechs are a high-risk industry where we have seen an increase in virtual business models. This allows companies to reach proof-of-concept without deploying large sums for capital equipment and infrastructure costs. At the other end of the biotech spectrum multi-billion dollar, publicly listed, biotech companies have also increased externalization of their sample management activities. Evotec has worked with companies from small startups […]
Read MoreBlog
SureClinical Announces Complimentary eClinical Applications for New COVID-19 Clinical Trials
Seeking the Fastest Path to Global Eradication of COVID-19 Virus Reno, Nevada, April 15 2020 – SureClinical, the premier provider of FDA and EU compliance validated eClinical cloud applications today announced a complimentary COVID-19 eClinical application program to support Clinical Research Organizations and Sponsors who are developing COVID-19 vaccines and treatments. With four active global […]
Read MoreImageDx: NASH – A New Generation of Quantitative NASH Data
Traditional NAFLD Activity Scoring Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of liver dysfunction, with some estimates suggesting up to 30% of the general population as being affected (1). NAFLD, while mainly asymptomatic, can progress to non-alcoholic steatohepatitis (NASH) in a portion of individuals. NASH is characterized by multiple pathologic […]
Read MorePharma Formulation Services Blog Series Part 3: From Lab to Suite Considerations for Scaling Up
When you finally arrive at a formulation that meets the target product profile, it is then necessary to devise a process by which it can be manufactured at scale. What started as a concept with beakers, stirring rods, and pipettes must become a process with bulk handling and automated or semi-automated equipment. Steps such as sifting, […]
Read MoreNeuroservices-Alliance biggest takeaways and lessons learned from projects and collaborations they’ve experienced throughout the year
So far, 2019 has been the year of building strong relationships between our members and reinforcing our ability to be a one-stop-shop CNS CRO thanks to our complimentary CNS platforms and our strong ensemble of experts. We participated in many of the main Neuroscience events worldwide and still have more to come (BIO Japan, Neuroscience […]
Read MorePharma Formulation Services Blog Series Part 2: Respect the Chemistry
Sometimes you have no choice. “You can have any color you want ‘so long as it is black.’” “Ice cream sold here: vanilla.” You get the idea. So it is with formulation. A substance will demand certain treatment. An API with the solubility of brick dust requires a dosage form to enhance solubility. An API […]
Read MorePharma Formulation Services Blog Series Part 1: Solving a Problem
The Role of Pharmaceutical Formulation Development Unlike other drug development activities, which are checkbox activities to meet FDA requirements, a good formulation solves a problem: “I’ve got this new molecule with fantastic in vitro activity, but how do I dose it? Will it be stable? Can I measure this? Is this suitable for the given […]
Read MoreLong & Short of USP Guidelines for EL Testing by Avomeen
Sources of Impurities in Pharmaceutical Products In the development of a drug product, careful consideration needs to be given to impurities that may originate from manufacturing equipment, process components, and packaging materials. The majority of such impurities are common chemical additives used to improve the physicochemical properties of a wide range of plastic materials. Suppliers […]
Read More